Solid Biosciences Cash on Hand 2016-2020 | SLDB

Solid Biosciences cash on hand from 2016 to 2020. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Solid Biosciences Annual Cash on Hand
(Millions of US $)
2019 $84
2018 $122
2017 $69
2016 $38
2015 $55
Solid Biosciences Quarterly Cash on Hand
(Millions of US $)
2020-03-31 $54
2019-12-31 $84
2019-09-30 $106
2019-06-30 $67
2019-03-31 $95
2018-12-31 $122
2018-09-30 $145
2018-06-30 $163
2018-03-31 $182
2017-12-31 $69
2017-09-30
2017-06-30
2017-03-31
2016-12-31 $38
2015-12-31 $55
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.136B $0.000B
Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001, a gene transfer candidate which is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients' muscles. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $135.120B 14.88
Gilead Sciences (GILD) United States $97.628B 12.65
CSL (CSLLY) Australia $84.053B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.661B 51.33
Regeneron Pharmaceuticals (REGN) United States $67.420B 25.99
Illumina (ILMN) United States $53.368B 54.84
Biogen (BIIB) United States $50.113B 8.58
Seattle Genetics (SGEN) United States $27.213B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.477B 11.38
Moderna (MRNA) United States $22.830B 0.00
Incyte (INCY) United States $22.153B 0.00
Genmab (GMAB) Denmark $19.891B 16.38
Genmab (GNMSF) Denmark $19.309B 57.33
BioMarin Pharmaceutical (BMRN) United States $19.268B 174.67
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.532B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.144B 38.92
Exact Sciences (EXAS) United States $12.860B 0.00
BeiGene (BGNE) Cayman Islands $12.803B 0.00
Sarepta Therapeutics (SRPT) United States $11.875B 0.00
BioNTech SE (BNTX) Germany $11.207B 0.00
Bio-Techne Corp (TECH) United States $10.121B 66.87
QIAGEN (QGEN) Netherlands $9.973B 29.00
Horizon Therapeutics Public (HZNP) Ireland $9.678B 23.82
ARGENX SE-ADR (ARGX) Netherlands $9.384B 0.00
Guardant Health (GH) United States $8.549B 0.00
Immunomedics (IMMU) United States $7.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.743B 0.00
Exelixis (EXEL) United States $7.578B 26.57
Ascendis Pharma (ASND) Denmark $6.981B 0.00
Repligen (RGEN) United States $6.850B 120.16
Acceleron Pharma (XLRN) United States $5.319B 0.00
Adaptive Biotechnologies (ADPT) United States $4.911B 0.00
Reata Pharmaceuticals (RETA) United States $4.830B 0.00
MyoKardia (MYOK) United States $4.775B 0.00
Emergent Biosolutions (EBS) United States $4.377B 28.69
China Biologic Products (CBPO) China $4.360B 24.24
Mirati Therapeutics (MRTX) United States $4.329B 0.00
Zai Lab (ZLAB) China $4.323B 0.00
Global Blood Therapeutics (GBT) United States $4.261B 0.00
MorphoSys AG (MOR) Germany $4.259B 33.03
Ultragenyx Pharmaceutical (RARE) United States $4.084B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.941B 86.11
Momenta Pharmaceuticals (MNTA) United States $3.705B 0.00
Bluebird Bio (BLUE) United States $3.541B 0.00
Blueprint Medicines (BPMC) United States $3.530B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.272B 0.00
Amicus Therapeutics (FOLD) United States $3.214B 0.00
Arena Pharmaceuticals (ARNA) United States $3.009B 0.00
UniQure (QURE) Netherlands $2.976B 0.00
Denali Therapeutics (DNLI) United States $2.940B 0.00
NeoGenomics (NEO) United States $2.811B 205.31
Novavax (NVAX) United States $2.668B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Alkermes (ALKS) Ireland $2.597B 51.13
Alector (ALEC) United States $2.584B 0.00
Fate Therapeutics (FATE) United States $2.520B 0.00
Insmed (INSM) United States $2.454B 0.00
Viela Bio (VIE) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.380B 0.00
Inovio Pharmaceuticals (INO) United States $2.332B 0.00
Principia Biopharma (PRNB) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.885B 0.00
Epizyme (EPZM) United States $1.774B 0.00
Zymeworks (ZYME) Canada $1.736B 0.00
Adverum Biotechnologies (ADVM) United States $1.657B 0.00
Ligand Pharmaceuticals (LGND) United States $1.630B 63.48
Dicerna Pharmaceuticals (DRNA) United States $1.594B 0.00
Sangamo Therapeutics (SGMO) United States $1.576B 0.00
Twist Bioscience (TWST) United States $1.555B 0.00
Zealand Pharma (ZEAL) Denmark $1.514B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Akcea Therapeutics (AKCA) United States $1.506B 0.00
Mesoblast (MESO) Australia $1.490B 0.00
Editas Medicine (EDIT) United States $1.489B 0.00
Arcus Biosciences (RCUS) United States $1.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.440B 0.00
I-Mab (IMAB) China $1.423B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
REGENXBIO (RGNX) United States $1.403B 0.00
Intra-Cellular Therapies (ITCI) United States $1.387B 0.00
NGM Biopharmaceuticals (NGM) United States $1.344B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.322B 9.23
Beam Therapeutics (BEAM) United States $1.315B 0.00
Arvinas (ARVN) United States $1.303B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.083B 55.88
Nabriva Therapeutics AG (NBRV) Ireland $1.079B 0.00
Sorrento Therapeutics (SRNE) United States $1.059B 0.00
Compugen (CGEN) Israel $1.053B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.959B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Athenex (ATNX) United States $0.887B 0.00
NextCure (NXTC) United States $0.859B 0.00
Heska (HSKA) United States $0.826B 0.00
Cue Biopharma (CUE) United States $0.787B 0.00
Cellectis S.A (CLLS) France $0.784B 0.00
Alcobra (ARCT) United States $0.775B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.752B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Codexis (CDXS) United States $0.733B 0.00
Kadmon Holdings (KDMN) United States $0.711B 0.00
Retrophin (RTRX) United States $0.677B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
NantKwest (NK) United States $0.664B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Vericel (VCEL) United States $0.649B 119.83
Vanda Pharmaceuticals (VNDA) United States $0.639B 5.48
Morphic Holding (MORF) United States $0.636B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.634B 0.00
Bellus Health (BLU) Canada $0.632B 0.00
Agenus (AGEN) United States $0.624B 0.00
Stemline Therapeutics (STML) United States $0.624B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.585B 0.00
Frequency Therapeutics (FREQ) United States $0.576B 0.00
Athersys (ATHX) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.564B 0.00
MeiraGTx Holdings (MGTX) United States $0.554B 0.00
Scholar Rock Holding (SRRK) United States $0.550B 0.00
DBV Technologies S.A (DBVT) France $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.532B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 0.00
AnaptysBio (ANAB) United States $0.520B 0.00
VBI Vaccines (VBIV) United States $0.503B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
UROGEN PHARMA (URGN) United States $0.490B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.479B 0.00
BioDelivery Sciences (BDSI) United States $0.478B 25.16
Anika Therapeutics (ANIK) United States $0.476B 15.31
Aquinox Pharmaceuticals (NLTX) United States $0.467B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
CytomX Therapeutics (CTMX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.402B 0.00
Albireo Pharma (ALBO) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.381B 327.00
ANI Pharmaceuticals (ANIP) United States $0.376B 7.45
Intrexon (PGEN) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.355B 0.00
Kamada (KMDA) Israel $0.349B 14.54
Avid Bioservices (CDMO) United States $0.330B 0.00
Geron (GERN) United States $0.327B 0.00
Menlo Therapeutics (MNLO) United States $0.326B 0.00
MannKind (MNKD) United States $0.322B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.316B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Verastem (VSTM) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
ADMA Biologics Inc (ADMA) United States $0.284B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.267B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Liquidia Technologies (LQDA) United States $0.262B 0.00
Starpharma Holdings (SPHRY) Australia $0.259B 0.00
Affimed (AFMD) Germany $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Exicure (XCUR) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
ARAVIVE, INC (ARAV) United States $0.204B 0.00
IVERIC Bio (ISEE) United States $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.200B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.194B 0.00
Cerecor (CERC) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
Aytu Bioscience (AYTU) United States $0.179B 0.00
Antibe Therapeutics (ATBPF) Canada $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Celyad SA (CYAD) Belgium $0.158B 0.00
TELA Bio (TELA) United States $0.157B 0.00
Arbutus Biopharma (ABUS) Canada $0.150B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Trevena (TRVN) United States $0.139B 0.00
Theratechnologies (THTX) Canada $0.139B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.131B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.107B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.093B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Organovo Holdings (ONVO) United States $0.082B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Happiness Biotech Group (HAPP) China $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Signal Genetics (MGEN) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
OvaScience (MLND) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Curis (CRIS) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.030B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00